BioCentury
ARTICLE | Company News

Aarhus University Hospital, Exiqon deal

October 12, 2015 7:00 AM UTC

Aarhus granted Exiqon exclusive rights to develop and commercialize two sets of biomarkers related to the diagnosis of prostate cancer via urine and tissue samples. Exiqon said the next step will be t...